
IVF · NASDAQ
INVO Fertility, Inc.
$0.59 -0.01 (-1.11%)
Company overview
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007, and is headquartered in Sarasota, FL.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $2.7M
- Employees
- 30
- Headquarters
- Sarasota, FL
- Website
- invobioscience.com
- CEO
- Steven Shum
- Listed
- November 2, 2020
- P/E
- -0.00
- Dividend yield
- 0.00%
Company financials
- Revenue
- $6.9M
- Gross profit
- $2.2M
- Operating income
- -$9.7M
- EBITDA
- -$8.4M
- Net income
- -$27.4M
- EPS
- -$181.62
- Total assets
- $18.8M
- Total debt
- $4.2M
- Gross margin
- 31.38%
- Net margin
- -394.91%
- Earnings yield
- -30,782.79%
No geographic segmentation.
Showing FY 2025